GSK-3β Phosphorylation of Cytoplasmic Dynein Reduces Ndel1 Binding to Intermediate Chains and Alters Dynein Motility

Traffic

Volumn 16, Issue 9, 2015, Pages 941-961

  Gao, Feng J ^a   Hebbar, Sachin ^b   Gao, Xu A ^a   Alexander, Michael ^a   Pandey, Jai P ^c   Walla, Michael D ^a   Cotham, William E ^a   King, Stephen J ^d   Smith, Deanna S ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Immune Tolerance Network   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Axon transport; Centrosome; Cytoplasmic dynein; Insulin; Ndel1 Nde1; Retrograde transport

Indexed keywords

CYTOPLASMIC DYNEIN; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN NDEL1; ROSIGLITAZONE; UNCLASSIFIED DRUG; CARRIER PROTEIN; DYNEIN ADENOSINE TRIPHOSPHATASE; GLYCOGEN SYNTHASE KINASE 3; NDEL1 PROTEIN, MOUSE; PROTEIN BINDING;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ORGANELLE; CELL PH; CENTROSOME; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INSULIN RESPONSE; LIQUID CHROMATOGRAPHY; MOUSE; NERVE CELL; NERVE FIBER TRANSPORT; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS CELL LINE; CYTOPLASM; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN TRANSPORT; SECOND MESSENGER; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CARRIER PROTEINS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; DYNEINS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INSULIN; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN TRANSPORT; SECOND MESSENGER SYSTEMS;

EID: 84939771192     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12304     Document Type: Article

References (75)

1. Baptista FI, Pinto MJ, Elvas F, Martins T, Almeida RD, Ambrosio AF. Diabetes induces changes in KIF1A, KIF5B and dynein distribution in the rat retina: implications for axonal transport. Exp Eye Res 2014;127:91-103.
2. Franker MA, Hoogenraad CC. Microtubule-based transport - basic mechanisms, traffic rules and role in neurological pathogenesis. J Cell Sci 2013;126:2319-2329.
3. Hirokawa N, Niwa S, Tanaka Y. Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron 2010;68:610-638.
4. Liu X, Gong H, Huang K. Oncogenic role of kinesin proteins and targeting kinesin therapy. Cancer Sci 2013;104:651-656.
5. Gennerich A, Vale RD. Walking the walk: how kinesin and dynein coordinate their steps. Curr Opin Cell Biol 2009;21:59-67.
6. Huang J, Roberts AJ, Leschziner AE, Reck-Peterson SL. Lis1 acts as a "clutch" between the ATPase and microtubule-binding domains of the dynein motor. Cell 2012;150:975-986.
7. McKenney RJ, Vershinin M, Kunwar A, Vallee RB, Gross SP. LIS1 and NudE induce a persistent dynein force-producing state. Cell 2010;141:304-314.
8. Fu MM, Holzbaur EL. Integrated regulation of motor-driven organelle transport by scaffolding proteins. Trends Cell Biol 2014;24:564-574.
9. Schlager MA, Hoang HT, Urnavicius L, Bullock SL, Carter AP. In vitro reconstitution of a highly processive recombinant human dynein complex. EMBO J 2014;33:1855-1868.
10. McKenney RJ, Huynh W, Tanenbaum ME, Bhabha G, Vale RD. Activation of cytoplasmic dynein motility by dynactin-cargo adapter complexes. Science 2014;345:337-341.
11. Schlager MA, Serra-Marques A, Grigoriev I, Gumy LF, Esteves da Silva M, Wulf PS, Akhmanova A, Hoogenraad CC. Bicaudal d family adaptor proteins control the velocity of dynein-based movements. Cell Rep 2014;8:1248-1256.
12. Rai AK, Rai A, Ramaiya AJ, Jha R, Mallik R. Molecular adaptations allow dynein to generate large collective forces inside cells. Cell 2013;152:172-182.
13. Lam C, Vergnolle MA, Thorpe L, Woodman PG, Allan VJ. Functional interplay between LIS1, NDE1 and NDEL1 in dynein-dependent organelle positioning. J Cell Sci 2010;123:202-212.
14. Pandey JP, Smith DS. A Cdk5-dependent switch regulates Lis1/Ndel1/dynein-driven organelle transport in adult axons. J Neurosci 2011;31:17207-17219.
15. Markus SM, Punch JJ, Lee WL. Motor- and tail-dependent targeting of dynein to microtubule plus ends and the cell cortex. Curr Biol 2009;19:196-205.
16. Roberts AJ, Goodman BS, Reck-Peterson SL. Reconstitution of dynein transport to the microtubule plus end by kinesin. ELife 2014;3:e02641.
17. Wu C, Cui B, He L, Chen L, Mobley WC. The coming of age of axonal neurotrophin signaling endosomes. J Proteomics 2009;72:46-55.
18. Rishal I, Fainzilber M. Axon-soma communication in neuronal injury. Nat Rev Neurosci 2014;15:32-42.
19. Dolma K, Iacobucci GJ, Hong Zheng K, Shandilya J, Toska E, White JA 2nd, Spina E, Gunawardena S. Presenilin influences glycogen synthase kinase-3 beta (GSK-3beta) for kinesin-1 and dynein function during axonal transport. Hum Mol Genet 2014;23:1121-1133.
20. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 2002;21:281-293.
21. Weaver C, Leidel C, Szpankowski L, Farley NM, Shubeita GT, Goldstein LS. Endogenous GSK-3/shaggy regulates bidirectional axonal transport of the amyloid precursor protein. Traffic 2013;14:295-308.
22. Baas PW, Lin S. Hooks and comets: the story of microtubule polarity orientation in the neuron. Dev Neurobiol 2011;71:403-418.
23. Eldar-Finkelman H. Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med 2002;8:126-132.
24. Marmol F. Lithium: bipolar disorder and neurodegenerative diseases possible cellular mechanisms of the therapeutic effects of lithium. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1761-1771.
25. Cole A, Frame S, Cohen P. Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. Biochem J 2004;377:249-255.
26. Nyarko A, Song Y, Barbar E. Intrinsic disorder in dynein intermediate chain modulates its interactions with NudE and dynactin. J Biol Chem 2012;287:24884-24893.
27. Hebbar S, Mesngon MT, Guillotte AM, Desai B, Ayala R, Smith DS. Lis1 and Ndel1 influence the timing of nuclear envelope breakdown in neural stem cells. J Cell Biol 2008;182:1063-1071.
28. Niethammer M, Smith DS, Ayala R, Peng J, Ko J, Lee MS, Morabito M, Tsai LH. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 2000;28:697-711.
29. Kuta A, Deng W, Morsi El-Kadi A, Banks GT, Hafezparast M, Pfister KK, Fisher EM. Mouse cytoplasmic dynein intermediate chains: identification of new isoforms, alternative splicing and tissue distribution of transcripts. PLoS One 2010;5:e11682.
30. Mitchell DJ, Blasier KR, Jeffery ED, Ross MW, Pullikuth AK, Suo D, Park J, Smiley WR, Lo KW, Shabanowitz J, Deppmann CD, Trinidad JC, Hunt DF, Catling AD, Pfister KK. Trk activation of the ERK1/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transport. J Neurosci 2012;32:15495-15510.
31. Sutherland C. What are the bona fide GSK3 Substrates? Int J Alzheimers Dis 2011;2011:505607.
32. McKenney RJ, Weil SJ, Scherer J, Vallee RB. Mutually exclusive cytoplasmic dynein regulation by NudE-Lis1 and dynactin. J Biol Chem 2011;286:39615-39622.
33. Wang S, Zheng Y. Identification of a novel dynein binding domain in nudel essential for spindle pole organization in Xenopus egg extract. J Biol Chem 2011;286:587-593.
34. Smith DS, Niethammer M, Ayala R, Zhou Y, Gambello MJ, Wynshaw-Boris A, Tsai LH. Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nat Cell Biol 2000;2:767-775.
35. Schuster M, Kilaru S, Ashwin P, Lin C, Severs NJ, Steinberg G. Controlled and stochastic retention concentrates dynein at microtubule ends to keep endosomes on track. EMBO J 2011;30:652-664.
36. Karak M, Bal NC, Bal C, Sharon A. Targeting peroxisome proliferator-activated receptor gamma for generation of antidiabetic drug. Curr Diabetes Rev 2013;9:275-285.
37. Jiang G, Zhang BB. Modulation of insulin signalling by insulin sensitizers. Biochem Soc Trans 2005;33:358-361.
38. Saltiel AR, Pessin JE. Insulin signaling pathways in time and space. Trends Cell Biol 2002;12:65-71.
39. Quintyne NJ, Schroer TA. Distinct cell cycle-dependent roles for dynactin and dynein at centrosomes. J Cell Biol 2002;159:245-254.
40. Liao H, Winkfein RJ, Mack G, Rattner JB, Yen TJ. CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis. J Cell Biol 1995;130:507-518.
41. Landberg G, Erlanson M, Roos G, Tan EM, Casiano CA. Nuclear autoantigen p330d/CENP-F: a marker for cell proliferation in human malignancies. Cytometry 1996;25:90-98.
42. Mesngon MT, Tarricone C, Hebbar S, Guillotte AM, Schmitt EW, Lanier L, Musacchio A, King SJ, Smith DS. Regulation of cytoplasmic dynein ATPase by Lis1. J Neurosci 2006;26:2132-2139.
43. Tripathy SK, Weil SJ, Chen C, Anand P, Vallee RB, Gross SP. Autoregulatory mechanism for dynactin control of processive and diffusive dynein transport. Nat Cell Biol 2014;16:1192-1201.
44. Bader JR, Kasuboski JM, Winding M, Vaughan PS, Hinchcliffe EH, Vaughan KT. Polo-like kinase1 is required for recruitment of dynein to kinetochores during mitosis. J Biol Chem 2011;286:20769-20777.
45. Whyte J, Bader JR, Tauhata SB, Raycroft M, Hornick J, Pfister KK, Lane WS, Chan GK, Hinchcliffe EH, Vaughan PS, Vaughan KT. Phosphorylation regulates targeting of cytoplasmic dynein to kinetochores during mitosis. J Cell Biol 2008;183:819-834.
46. Yamada M, Toba S, Yoshida Y, Haratani K, Mori D, Yano Y, Mimori-Kiyosue Y, Nakamura T, Itoh K, Fushiki S, Setou M, Wynshaw-Boris A, Torisawa T, Toyoshima YY, Hirotsune S. LIS1 and NDEL1 coordinate the plus-end-directed transport of cytoplasmic dynein. EMBO J 2008;27:2471-2483.
47. Sato N, Morishita R. Brain alterations and clinical symptoms of dementia in diabetes: abeta/tau-dependent and independent mechanisms. Front Endocrinol 2014;5:143.
48. Eschbach J, Dupuis L. Cytoplasmic dynein in neurodegeneration. Pharmacol Ther 2011;130:348-363.
49. Eschbach J, Sinniger J, Bouitbir J, Fergani A, Schlagowski AI, Zoll J, Geny B, Rene F, Larmet Y, Marion V, Baloh RH, Harms MB, Shy ME, Messadeq N, Weydt P, et al. Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age. Neurobiol Dis 2013;58:220-230.
50. Velebit J, Chowdhury HH, Kreft M, Zorec R. Rosiglitazone balances insulin-induced exo- and endocytosis in single 3T3-L1 adipocytes. Mol Cell Endocrinol 2011;333:70-77.
51. Huang J, Imamura T, Olefsky JM. Insulin can regulate GLUT4 internalization by signaling to Rab5 and the motor protein dynein. Proc Natl Acad Sci U S A 2001;98:13084-13089.
52. Hernandez R, Teruel T, Lorenzo M. Rosiglitazone produces insulin sensitisation by increasing expression of the insulin receptor and its tyrosine kinase activity in brown adipocytes. Diabetologia 2003;46:1618-1628.
53. Kariharan T, Nanayakkara G, Parameshwaran K, Bagasrawala I, Ahuja M, Abdel-Rahman E, Amin AT, Dhanasekaran M, Suppiramaniam V, Amin RH. Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression. Neurobiol Aging 2015;36:1451-1461.
54. Watson GS, Craft S. The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs 2003;17:27-45.
55. Herrigel DJ, Moss RA. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies. Postgrad Med 2014;126:106-118.
56. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679-1687.
57. Lefebvre AM, Chen I, Desreumaux P, Najib J, Fruchart JC, Geboes K, Briggs M, Heyman R, Auwerx J. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 1998;4:1053-1057.
58. Su W, Bush CR, Necela BM, Calcagno SR, Murray NR, Fields AP, Thompson EA. Differential expression, distribution, and function of PPAR-gamma in the proximal and distal colon. Physiol Genomics 2007;30:342-353.
59. Barton NR, Goldstein LS. Going mobile: microtubule motors and chromosome segregation. Proc Natl Acad Sci U S A 1996;93:1735-1742.
60. Kotak S, Gonczy P. Mechanisms of spindle positioning: cortical force generators in the limelight. Curr Opin Cell Biol 2013;25:741-748.
61. Raaijmakers JA, Medema RH. Function and regulation of dynein in mitotic chromosome segregation. Chromosoma 2014;123:407-422.
62. Acevedo N, Wang X, Dunn RL, Smith GD. Glycogen synthase kinase-3 regulation of chromatin segregation and cytokinesis in mouse preimplantation embryos. Mol Reprod Dev 2007;74:178-188.
63. Bobinnec Y, Morin X, Debec A. Shaggy/GSK-3beta kinase localizes to the centrosome and to specialized cytoskeletal structures in Drosophila. Cell Motil Cytoskeleton 2006;63:313-320.
64. Fumoto K, Lee PC, Saya H, Kikuchi A. AIP regulates stability of Aurora-A at early mitotic phase coordinately with GSK-3beta. Oncogene 2008;27:4478-4487.
65. Harwood AJ, Forde-Thomas JE, Williams H, Samereier M, Muller-Taubenberger A. Aberrant spindle dynamics and cytokinesis in Dictyostelium discoideum cells that lack glycogen synthase kinase 3. Eur J Cell Biol 2013;92:222-228.
66. Izumi N, Fumoto K, Izumi S, Kikuchi A. GSK-3beta regulates proper mitotic spindle formation in cooperation with a component of the gamma-tubulin ring complex, GCP5. J Biol Chem 2008;283:12981-12991.
67. Tighe A, Ray-Sinha A, Staples OD, Taylor SS. GSK-3 inhibitors induce chromosome instability. BMC Cell Biol 2007;8:34.
68. Wakefield JG, Stephens DJ, Tavare JM. A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment. J Cell Sci 2003;116:637-646.
69. Wojcik EJ. A mitotic role for GSK-3beta kinase in Drosophila. Cell Cycle 2008;7:3699-3708.
70. Marlin MC, Li G. Biogenesis and function of the NGF/TrkA signaling endosome. Int Rev Cell Mol Biol 2015;314:239-257.
71. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci U S A 1993;90:587-591.
72. King SJ, Brown CL, Maier KC, Quintyne NJ, Schroer TA. Analysis of the dynein-dynactin interaction in vitro and in vivo. Mol Biol Cell 2003;14:5089-5097.
73. Gurnell M, Wentworth JM, Agostini M, Adams M, Collingwood TN, Provenzano C, Browne PO, Rajanayagam O, Burris TP, Schwabe JW, Lazar MA, Chatterjee VK. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J Biol Chem 2000;275:5754-5759.
74. Culver-Hanlon TL, Lex SA, Stephens AD, Quintyne NJ, King SJ. A microtubule-binding domain in dynactin increases dynein processivity by skating along microtubules. Nat Cell Biol 2006;8:264-270.
75. Bingham JB, King SJ, Schroer TA. Purification of dynactin and dynein from brain tissue. Methods Enzymol 1998;298:171-184.